Dudediligence.

Mangoceuticals, Inc

MGRXNASDAQ · Services-Misc Health & Allied Services, NEC
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

18.0M

on 2026-06-30, from 3.25M on 2024-12-31 10-Q ↗

Counts before 2024-12-31 are left out: the count went from 32.0M on 2024-09-30 to 3.25M on 2024-12-31, a change no split on file explains.

a raise that quarter, at its price

5M10M15MDec2024Mar2025JunSepDec$1.295Mar2026Jun

Newest

$150.0M

S-3 of 2025-06-13. 1 prospectus supplement filed under it since. S-3 ↗

15 of its filings are not read yet.

Warrants

3.41M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

0.2 quarters

$229K on 2026-06-30 ÷ $973K a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-12-18Public offeringnot read$1.295$2.5M424B5 ↗